Our revolutionary method for molecular diagnostics, enabling limitless testing possibilities.
Our CRISPR-powered diagnostics provide unambiguous results in an instrument-free and disposable format.
Signal amplification by CRISPR accelerates target detection and is compatible with multiple sample matrices.
DETECTR® can be quickly tailored to identify any DNA or RNA target using our CRISPR nuclease toolbox and gRNA design pipeline.
DETECTR® searches for the presence of specific nucleic acids in a sample that are indicative of disease, providing actionable clinical information.
Our proprietary testing system works by employing CRISPR nucleases, programmed to find a defined gene sequence. Upon finding the sequence of interest, the nuclease activates a cleavage capability, which generates a signal. The signal confirms the sequence has been found.
At Mammoth we’re bringing CRISPR out of the lab and into everyday life.
Affordable and timely molecular detection is needed in hospitals, point of care settings, and homes. Our DETECTR® platform can be integrated into different products by ourselves or our partners with an expansive test menu.
Please get in touch with us about how your company or organization would like to revolutionize disease detection using our DETECTR® or DETECTR BOOST® platforms.